HighQC™ Human IPSC-Derived Neural Stem Cell MAPT V337M HOM
Human Human IPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the V337M mutation (CGG>TGG) into the MAPT gene. This line is homozygous for the V337M mutation so both alleles contain the mutation.
Product Specifications
Applications
For research use only
Storage Conditions
Liquid Nitrogen
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881045-100 1x 100 µL
CD16 (C16/1045), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401081-500 1x 500 µL
CD45RO (190-2F2.5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC050391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC551037-500 1x 500 µL
CD44 Standard (DF1485), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470788-100 1x 100 µL
MART-1 / Melan-A (MLANA/788), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details